Effects of siRNA TMPRSS2-ERG III and IV on cell death pathways. by Giorgia Urbinati (554921)

The initiation region/matrix attachment region (IR/MAR) increased the homogeneously staining region (HSR) elongation rate and decreased the frequency of micronuclei after elevation... by Shun-suke Tanaka (604228)

Arginine supplementation decreases the inhibitory effect exerted by 5-flucytosine in <i>C</i>. <i>glabrata</i>. by Catarina Costa (322963)

miR-146b-5p expression is decreased in monocytes of obese subjects and is regulated by globular adiponectin. by Maarten Hulsmans (181118)

Mean signal intensities obtained for each analyte at three different tissue-to-solvent volume proportions. by Ewa Paszkowska (21246702)

Subjects:

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

“…The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. …”

Mean <i>μ</i>_<i>i</i> and standard deviation <i>σ</i>_<i>i</i> of <i>i</i> = [0%, 1%, 2.5%, 5%] concentration datasets. by Ishriak Ahmed (14265562)

Barbie’s ankle equinus measured at 50 degrees as equnius posture (a) and flat foot posture measured at 0 degrees (b), with a handheld goniometer. by Cylie Williams (3446018)

Scree plot curve of 50 CIs created by each number of models. by Hitoshi Biwasaka (19923867)

List of mRNAs that are differentially expressed in both the RNAPII ChIP-seq and RNA-seq datasets, mRNAs with decreased expression in both lists, and mRNAs that have decreased expre... by Katherine I. Farley-Barnes (9258036)

“…<p>List of mRNAs that are differentially expressed in both the RNAPII ChIP-seq and RNA-seq datasets, mRNAs with decreased expression in both lists, and mRNAs that have decreased expression in both lists and are also nucleolar in at least 1 database [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref050" target="_blank">50</a>–<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref052" target="_blank">52</a>].…”

Effects of A1AR expression on response to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

“…<p>A: At E9.5, responses to hypoxia in A1AR −/− (n = 15) and A1AR +/− (n = 50) embryos were studied. …”

Mean scores and 95% CI of mental health symptoms, COVID-19 admissions and effect size during follow-up. by A. H. Ayesha Lavell (16734002)

Subjects:

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

EIF5A2 or MTA1 expression levels influenced the aggressiveness of GC cells in vitro. by Qing-Bin Meng (707083)

“…Column, mean; bars, ±SD (from triplicates). (<b>C</b>) Proliferation of EIF5A2-plasmid and control plasmid MKN45 cells were measured by CCK-8 assay every 24 h after plasmid transfection. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

BMS-754807 decreases AKT phosphorylation in DIPG cell-lines cultured in serum-free media. by Kyle G. Halvorson (699837)

Decrease in proliferation after ENU-exposure as decrease in BrdU immunostaining. by Vivian Capilla-Gonzalez (336046)

“…<p>Micrograph of the BrdU+ cells immunolabeled with DAB showed a decrease in the proliferation in the SVZ (B) and DG (D) of treated animals, compared with control group (A and C, respectively). …”

Total plasma cortisol concentration over time following intramuscular administration of either 0.1 mL saline, 0.4 mg/kg meloxicam, 2.2 mg/kg flunixin or 3.0 mg/kg ketoprofen in 6-d... by Emma Nixon (11772946)

Subjects:

The relation of BMI Z-scores at one year and the variability of blood phenylalanine levels in the first year of life for infants with PKU and MHP—Carriers of the rs113883650 varian... by Miroslaw Bik-Multanowski (5700350)

Subjects:

Total ISF PGE2 concentration over time (accounting for ISF probe lag time) following intramuscular administration of either 0.1 mL saline, 0.4 mg/kg meloxicam, 2.2 mg/kg flunixin o... by Emma Nixon (11772946)

Subjects: